ERBB.0505/TALK.08-Distribution Deal iTalk: Inks M2M

New Post Public Reply Private Reply Replies (0) Message Board
FLA
ERBB.0505/TALK.08-Distribution Deal

iTalk: Inks M2M Medical Marijuana Distribution Deal
Connected Machines Will Fast Become Core Revenue Streams for iTalk 04/22 10:00 PM



FORT LAUDERDALE, Fla., April 22, 2014 (GLOBE NEWSWIRE) -- iTalk, Inc. (TALK:$0.08,00$-0.009,0-10.11%) a global provider of advanced communications and mobile broadband services and the Tranzbyte Corporation (ERBB:$0.0505,$-0.0056,-9.98%) announced today that it has signed a distribution agreement for the iTalk premier cloud connectivity solution "CloudTalk".
CloudTalk is the medical marijuana dispensary industry's first ultra-secure connectivity to the cloud for vending machines and credit card processing, which is critical to creating a secure operational environment for these processes. Next generation products will include biometrics, machine virtualization and ultra-secure storage and access solutions. The need for ultra-secure connectivity to alternative medical dispensary machines has never been greater; the CloudTalk is the only product that specifically targets these specialized vending machines and processes. Next Generation Biometric Market worth $23.54 Billion by 2020.
"Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) is a premier alternative technology company whose product ZaZZZ(tm) facilitates legal sale and dispensation of age-controlled products. When we can enhance our technology with ultra-secure connectivity that enables worry free ecommerce processes in an environment where consumer data security concerns are at an all-time high, it is important to choose the right partner. iTalk's new CloudTalk is the product that stands out ahead of the rest," stated Stephen Shearin, Chief Operating Officer for Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) .
"We have chosen an innovator in the alternative medical space to launch the distribution of CloudTalk. We are excited to be working with an industry giant such as Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) . Our secure mobile connectivity solution, 'CloudTalk', mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices which will allow for ultra-secure medical marijuana purchases without the risk or exposure of consumer data," stated David F. Levy, iTalk CEO.
About iTalk
iTalk, Inc. (TALK:$0.08,00$-0.009,0-10.11%) is a publicly traded global provider of advanced communications and mobile broadband services. The Company utilizes innovative and disruptive technologies, including Voice-over-IP (VoIP), nationwide 3G/4G mobile broadband networks, smartphones, and mobile applications ("apps" to offer consumers the highest-quality low-cost no-contract alternatives to voice, data, and mobile services from major national carriers. Through our access to an extensive network, iTalk is able to offer nationwide voice and data coverage to 280 million people in more than 12,900 cities. For further information, visit www.italkmobility.com.
ABOUT TRANZBYTE (ERBB:$0.0505,$-0.0056,-9.98%)
The Tranzbyte Corporation (ERBB:$0.0505,$-0.0056,-9.98%) (www.tranzbyte.com) is a driving force behind American Green, OneBode, The YO! Debit Card, and BancoLibre. The company expects to continue its plan to acquire, hold, or spin out successful divisions in what has been described in previous news releases as "dividend farming." Companies that qualify and decide to become public on their own will agree to carve out shares for Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) and dividends for their ERBB shareholders. Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) also houses the company's 10-year-old technology division which is actively engaged in the sale of its optical media enhancement products to potential customers in the US and Asia. Products in the Tranzbyte (ERBB:$0.0505,$-0.0056,-9.98%) division include FLASHAlbum™ and FlixStix -- technologies that the company plans to be incorporated into the Company's ZaZZZ Machine while enabling distributors of optical media (CDs, DVDs, etc.) to consolidate the best features of each medium onto a single content-protected USB flash drive.
ABOUT AMERICAN GREEN
American Green, formally Altitude Organix, became the first publicly traded medical marijuana dispensary brand in the world as American Green Corporation. Beginning in 2009, the company has developed retailing, branding, and commercial cultivating strategies in conjunction with its licensed medical marijuana retail dispensaries operating under the Altitude Organic Medicine brand name. While the Company is no longer associated with the Altitude Organic Medicine outlets in Colorado, it has spent the last year developing an "automated dispensary" that will offer the company's proprietary products to qualified adults in the US and around the world under its "American Green" brand. The Company's newly acquired YO! Debit Card has been rebranded as "ZaZZZ" for use in its proprietary machines and will be accepted at participating dispensaries and other select locations who become members of the ZaZZZ Network.
Disclaimer/Safe Harbor: Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic.
CONTACT: iTalk, Inc (TALK:$0.08,00$-0.009,0-10.11%) David F. Levy / CEO
marketing@italkmobility.com

Tranzbyte Corporation (ERBB:$0.0505,$-0.0056,-9.98%) David G. Gwyther/ President
davidgwyther@tranzbyte.com
http://www.tranzbyte.com
Image: iTalk, Inc Logo


Get more news on:SYMBOLS: TALK, ERBBNEWS TYPE: SECTORS: Consumer Discretionary, Internet and Catalog Retail, Media, Health Care, Industrials, Commercial Services and Supplies, Information Technology, Computers and Peripherals, IT Services

Eat dessert 1st! ---- Life is short & unpredictable!
I ONLY POST WHAT I PLAY
I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading